Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice-President Jay Taylor has expressed the organization’s concerns over the Office of the United States Trade Representative’s (USTR) 2013 Special 301 Report.
Susan Haigney
Advertisement
Susan Haigney is managing editor of Pharmaceutical Technologyand Pharmaceutical Technology Europe, susan.haigney@ubm.com.
Articles by Susan Haigney
Developing and maintaining the right labor pool is an ongoing challenge for any industry, and it is one that the pharmaceutical industry also is facing.
Advertisement
Latest Updated Articles
- Pharma's Shifting Needs for Scientific Talent
Published: February 6th 2013 | Updated:
- PhRMA Dismayed by Global IPR Report
Published: May 6th 2013 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
